Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Oncogene
.
2021 Aug;40(32):5153.
doi: 10.1038/s41388-021-01929-9.
Authors
Min Guo
1
2
,
Kaveh M Goudarzi
3
,
Shiva Abedi
4
,
Melanie Pieber
5
,
Elin Sjöberg
6
,
Jinan Behnan
7
8
,
Xing-Mei Zhang
5
,
Robert A Harris
5
,
Jiri Bartek
9
10
,
Mikael S Lindström
9
,
Monica Nistér
4
,
Daniel Hägerstrand
11
12
Affiliations
1
Department of Oncology-Pathology, Karolinska Institutet, BioClinicum, Solna, Sweden. min.guo@ki.se.
2
Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. min.guo@ki.se.
3
Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden.
4
Department of Oncology-Pathology, Karolinska Institutet, BioClinicum, Solna, Sweden.
5
Department of Clinical Neuroscience, Karolinska Institutet, Centre for Molecular Medicine, Solna, Sweden.
6
Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
7
Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
8
Department of Neurosurgery, Albert Einstein College of Medicine, Bronx, NY, USA.
9
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
10
The Danish Cancer Society Research Centre, Copenhagen, Denmark.
11
Department of Oncology-Pathology, Karolinska Institutet, BioClinicum, Solna, Sweden. daniel.hagerstrand@ki.se.
12
Department of Molecular Medicine and Surgery, Karolinska Institutet, BioClinicum, Solna, Sweden. daniel.hagerstrand@ki.se.
PMID:
34257430
PMCID:
PMC8363096
DOI:
10.1038/s41388-021-01929-9
No abstract available
Publication types
Published Erratum